EUVIMEDEUVIMED entdecken
Crossref

Evaluate of the protective effect of an RSV Pre‐F/Alum +CpG subunit vaccine in Balb/C mice with and without RSV prexposure

Ning Luan, Heng Zhang, Zhentao Lei, Rong Bi, Han Cao, Dandan Gao, Qiuju He, Xiaolong Zhang, Qianqian Li, Cunbao Liu

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70971 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Ning Luan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Respiratory Syncytial Virus Vaccines, Alum Compounds, Viral Fusion Proteins. Die Arbeit nennt 36 Literaturangaben. Gefördert von: National Key R&D Program of China, Yunnan Fundamental Research Projects, Yunnan Provincial Health Commission Medical Reserve Talents Training Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory syncytial virus (RSV) poses a substantial global health threat. Most individuals have been infected with RSV at least once prior to vaccination, resulting in the presence of pre‐existing antibodies. In this study, Balb/C mice were either pre‑exposed or non‐pre‐exposed to RSV on day 0, followed by a two‐dose regimen of an RSV subunit vaccine on days 28 and 56. Two prefusion RSV F proteins (Pre‐F‐1 and Pre‐F‐2) were designed as vaccine antigens, formulated with Alum + CpG adjuvant to promote a Th1‐biased response. Results showed that once pre‐exposed to RSV (PC group), a robust immune activation was induced in the mice. Compared with the non‐pre‐exposed control (nPC group), the PC group exhibited a continued rise of postfusion‐F (post‐F)‐specific IgG binding titers and neutralizing antibody (nAbs) against RSV A2 over 77 days, leading to a reduced lung viral load upon rechallenge. However, the PC group also showed greater weight loss and higher lung histopathological scores (HPS). In pre‐exposed mice, a single vaccine dose steadily increased both binding titers and nAbs, while a two‐dose regimen reversed the post‐F/pre‐F ratio and slightly lowered pulmonary viral load. In non‐pre‐exposed mice, two‐doses of vaccination increased binding titers and nAbs, reduced weight loss, and significantly decreased lung viral load. This study highlights the importance of prior RSV infection status in designing and clinically translating adjuvanted subunit RSV vaccines. Our results indicate that in pre‐exposed Balb/C mice, high preexisting post‐F titers can affect subsequent vaccine immune responses and protective efficacy. This study also demonstrates that the immunological background of whether mice have been pre‐exposed with RSV can significantly influence the evaluation of RSV subunit vaccine immunogenicity and protective efficacy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Syncytial Virus InfectionsRespiratory Syncytial Virus VaccinesAlum CompoundsViral Fusion ProteinsOligodeoxyribonucleotidesPre-Exposure ProphylaxisAnimalsMice, Inbred BALB CAntibodies, ViralFemaleVaccines, SubunitAdjuvants, ImmunologicLungAntibodies, NeutralizingMiceProtein Subunit VaccinesImmunoglobulin GViral LoadDisease Models, AnimalVaccine Efficacy

Stichwörter der Autor:innen

Alum + CpGRSVpre‐Fprime infectionsubunit vaccine

Substanzen

Respiratory Syncytial Virus VaccinesAntibodies, ViralAlum CompoundsVaccines, SubunitAdjuvants, Immunologicaluminum sulfateAntibodies, NeutralizingProtein Subunit VaccinesImmunoglobulin GViral Fusion Proteins

Autor:innen und Institutionen

  • Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.

Förderung

  • National Key R&D Program of China
  • Yunnan Fundamental Research Projects
  • Yunnan Provincial Health Commission Medical Reserve Talents Training Program
  • Funds for the Training of High-Level Health Technical Personnel in Yunnan Province
  • Funds for High-Level Scientific and Technological Talents Selection Special Project of Yunnan Province
  • CAMS Innovation Fund for Medical Sciences (CIFMS)

Zitieren

APA

Luan, N., Zhang, H., Lei, Z., Bi, R., Cao, H., Gao, D., He, Q., Zhang, X., Li, Q., & Liu, C. (2026). Evaluate of the protective effect of an RSV Pre‐F/Alum +CpG subunit vaccine in Balb/C mice with and without RSV prexposure. Journal of Medical Virology. https://doi.org/10.1002/jmv.70971

Vancouver

Luan N, Zhang H, Lei Z, Bi R, Cao H, Gao D, et al. Evaluate of the protective effect of an RSV Pre‐F/Alum +CpG subunit vaccine in Balb/C mice with and without RSV prexposure. Journal of Medical Virology. 2026. doi:10.1002/jmv.70971

BibTeX
@article{Luan2026,
  author = {Luan, Ning and Zhang, Heng and Lei, Zhentao and Bi, Rong and Cao, Han and Gao, Dandan and He, Qiuju and Zhang, Xiaolong and Li, Qianqian and Liu, Cunbao},
  title = {Evaluate of the protective effect of an RSV Pre‐F/Alum +CpG subunit vaccine in Balb/C mice with and without RSV prexposure},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70971}
}
Kostenlos starten →